UNSPSC 51442722: Technetium Tc-99m tilmanocept or technetium 99mtc tilmanocept

This classification denotes a radioconjugate, generally known as Technetium Tc 99m tilmanocept. The term Technetium Tc-99m tilmanocept is an International Non-Proprietary Name or INN. In general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer. This commodity aids in lymphatic studies. Most nations schedule Technetium Tc-99m tilmanocept or technetium 99mtc tilmanocept under HS 28444030.

UNSPSC 51442722 Technetium Tc-99m tilmanocept or technetium 99mtc tilmanocept is a Commodity code that nominally covers radiopharmaceutical diagnostic imaging agents; however, recent state and local opportunities show no relevant activity under this specific code. The most recent opportunities posted against this code span radiologic equipment procurement, X-ray maintenance services, and unrelated chemical supplies — none of which are radiopharmaceuticals or diagnostic imaging agents. Maricopa County Community College District posted an IFB for radiologic equipment and installation at three colleges; Escambia County Correction sought extended warranty coverage for existing X-ray equipment; Broward County Aviation Department issued an RFI for Rapiscan X-ray system maintenance services; and Pasco County solicited copper sulfate chemicals on an as-needed basis. These opportunities indicate broad misalignment between the code's nominal scope and current state and local procurement activity.

The geographic spread reflects activity across Florida (Escambia, Broward, and Pasco counties) and Arizona (Maricopa County). The issuing bodies include county governments and a county-operated community college district, with no state-level purchases or school district procurement visible in recent postings. Because the code shows no substantive recent activity aligned with its stated product scope — technetium-based radiopharmaceuticals used in diagnostic nuclear imaging — vendors in this space should monitor the code for future activity but should not expect near-term state and local opportunities under this classification.